{"id":81979,"date":"2026-06-15T17:16:58","date_gmt":"2026-06-15T21:16:58","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/adaptive-biotechnologies-plans-to-split-drug-discovery-and-cancer-testing-units\/"},"modified":"2026-06-15T17:16:58","modified_gmt":"2026-06-15T21:16:58","slug":"adaptive-biotechnologies-plans-to-split-drug-discovery-and-cancer-testing-units","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/adaptive-biotechnologies-plans-to-split-drug-discovery-and-cancer-testing-units\/","title":{"rendered":"Adaptive Biotechnologies Plans to Split Drug Discovery and Cancer Testing Units"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?resize=1920%2C1080&#038;ssl=1\" alt=\"\" class=\"wp-image-81978\" srcset=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?w=1920&amp;ssl=1 1920w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?resize=300%2C169&amp;ssl=1 300w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?resize=1024%2C576&amp;ssl=1 1024w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?resize=768%2C432&amp;ssl=1 768w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?resize=1536%2C864&amp;ssl=1 1536w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><\/figure>\n\n\n<p>Adaptive Biotechnologies announced Monday that it plans to split its immune medicine operation away from its cancer-testing division, as the company weighs what to do with its drug-discovery business and doubles down on diagnostic testing.<\/p><p>The company said it is currently exploring all available options for the immune medicine platform and expects to settle on a preferred course of action by the close of 2026.<\/p><p>Adaptive&#8217;s immune medicine platform is designed to assist in drug research by pinpointing therapeutic targets and speeding up the development of precision-based treatments.<\/p><p>Meanwhile, the company&#8217;s cancer-testing division \u2014 which includes its clonoSEQ diagnostic test \u2014 has turned a profit and expanded its coverage through insurance providers, the company said.<\/p><p>The clonoSEQ test is used to detect tiny amounts of cancer that may still be present in a patient&#8217;s body following treatment, and it is also utilized in drug-development research studies.<\/p><p>Revenue from the cancer-testing unit climbed to $212 million in 2025, up significantly from $103 million in 2023, according to the company.<\/p><p>Adaptive indicated that the immune medicine business may be a better fit outside of the company&#8217;s diagnostics-centered structure.<\/p><p>The company cautioned that there is no guarantee the review process will lead to a transaction or any specific result.<\/p>","protected":false},"excerpt":{"rendered":"<p>Adaptive Biotechnologies announced Monday it intends to separate its immune medicine platform from its cancer-testing division. The company is exploring options for the drug-discovery side of the business while shifting its focus toward diagnostics. A decision on the preferred direction is expected before the end of 2026.<\/p>\n","protected":false},"author":4,"featured_media":81978,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[834],"tags":[],"class_list":["post-81979","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781558217735.png?fit=1920%2C1080&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-lkf","jetpack-related-posts":[{"id":44256,"url":"https:\/\/tvdelmarva.com\/wp\/pharmaceutical-giant-eli-lilly-expands-ai-drug-discovery-deal-worth-2-75-billion\/","url_meta":{"origin":81979,"position":0},"title":"Pharmaceutical Giant Eli Lilly Expands AI Drug Discovery Deal Worth $2.75 Billion","author":"Admin","date":"March 29, 2026","format":false,"excerpt":"Eli Lilly has expanded its artificial intelligence partnership with Insilico Medicine in a deal potentially worth $2.75 billion. The collaboration focuses on using AI technology to accelerate the development of new oral medications currently in early testing phases.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1774830131178.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":51913,"url":"https:\/\/tvdelmarva.com\/wp\/amazon-unveils-new-ai-tool-to-accelerate-drug-development-process\/","url_meta":{"origin":81979,"position":1},"title":"Amazon Unveils New AI Tool to Accelerate Drug Development Process","author":"Admin","date":"April 14, 2026","format":false,"excerpt":"Amazon's cloud division has introduced an artificial intelligence platform called Amazon Bio Discovery that helps scientists identify potential drug candidates without requiring coding skills. The technology can generate hundreds of drug possibilities in weeks rather than the traditional 18-month timeline.","rel":"","context":"In &quot;Science&quot;","block_context":{"text":"Science","link":"https:\/\/tvdelmarva.com\/wp\/category\/science\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1776180144421.jpg?fit=450%2C278&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":59729,"url":"https:\/\/tvdelmarva.com\/wp\/medical-testing-giant-labcorp-boosts-annual-profit-projections-after-strong-quarter\/","url_meta":{"origin":81979,"position":2},"title":"Medical Testing Giant Labcorp Boosts Annual Profit Projections After Strong Quarter","author":"Admin","date":"April 30, 2026","format":false,"excerpt":"Laboratory Corporation of America increased its yearly earnings outlook Thursday following first-quarter results that exceeded Wall Street expectations. The company's diagnostic testing business showed consistent growth, helping offset weaker performance in its drug development services division.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1777551852943.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":72574,"url":"https:\/\/tvdelmarva.com\/wp\/meta-ceos-charity-launches-ai-tool-to-speed-up-drug-development\/","url_meta":{"origin":81979,"position":3},"title":"Meta CEO&#8217;s Charity Launches AI Tool to Speed Up Drug Development","author":"Admin","date":"May 27, 2026","format":false,"excerpt":"A charitable organization founded by Meta CEO Mark Zuckerberg and his wife has introduced an artificial intelligence system designed to help scientists develop new medications more quickly. The technology uses evolutionary modeling to better understand protein biology and has shown promising results in cancer and immune disease research.","rel":"","context":"In &quot;Science&quot;","block_context":{"text":"Science","link":"https:\/\/tvdelmarva.com\/wp\/category\/science\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1779884572700.jpg?fit=450%2C291&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":26941,"url":"https:\/\/tvdelmarva.com\/wp\/british-drugmaker-gsk-purchases-canadian-biotech-firm-for-nearly-1-billion\/","url_meta":{"origin":81979,"position":4},"title":"British Drugmaker GSK Purchases Canadian Biotech Firm for Nearly $1 Billion","author":"Admin","date":"February 25, 2026","format":false,"excerpt":"Pharmaceutical giant GSK announced Wednesday it will acquire Canadian company 35Pharma for $950 million cash. The purchase gives GSK access to an experimental treatment for a deadly lung condition called pulmonary hypertension.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1772008269026.jpg?fit=450%2C303&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":30982,"url":"https:\/\/tvdelmarva.com\/wp\/japanese-drugmaker-halts-skin-treatment-trials-over-cancer-concerns\/","url_meta":{"origin":81979,"position":5},"title":"Japanese Drugmaker Halts Skin Treatment Trials Over Cancer Concerns","author":"Admin","date":"March 3, 2026","format":false,"excerpt":"Pharmaceutical company Kyowa Kirin has terminated all clinical trials for an experimental skin condition medication after safety reviews revealed potential cancer risks. The drug was being tested to treat severe eczema and other inflammatory skin disorders.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772547661813.png?fit=1200%2C675&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772547661813.png?fit=1200%2C675&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772547661813.png?fit=1200%2C675&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772547661813.png?fit=1200%2C675&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772547661813.png?fit=1200%2C675&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/81979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=81979"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/81979\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/81978"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=81979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=81979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=81979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}